Growth hormone treatment of children with brain tumors and risk of tumor recurrence.

Published in: J Clin Endocrinol Metab
By: Swerdlow AJ, Reddingius RE, Higgins CD, et al.

Long-term risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone

Published in: J Parenter Enteral Nutr
By: Tacke J, Bolder U, Herrmann A, et al.

Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer.

Published in: Lancet
By: Hankinson SE, Willett WC, Colditz GA, et al.

Malignant disease and cardiovascular morbidity in hypopituitary adults with or without hormone replacement therapy.

Published in: J Clin Endocrinol Metab
By: Svensson J, Bengtsson BA° , Ros_en T, et al.

Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study.

Published in: Science
By: Chan JM, Stampfer MJ, Giovannucci E, et al.

Growth hormone therapy and malignancy.

Published in: Horm Res
By: Shalet SM, Brennan BM, Reddingius RE.

Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectoal cancer: a prospective study in northern Sweden.

Published in: Gut
By: Palmqvist R, Hallmans G, Rinaldi S, et al.

Insulin-like growth factors and prostate cancer

Published in: Epidemiol Rev
By: Pollak M.

Insulin-like growth factor-1 and breast cancer risk in postmenopausal African-American women.

Published in: Cancer Detect Prev
By: Agurs-Collins T, Adams-Campbell LL, Kim KS, et al.

Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia.

Published in: J Clin Oncol
By: Leung W, Zhou Y, Hancock ML, et al.

Pages